JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, cilt.44, sa.7, ss.1284-1293, 2018 (SCI-Expanded)
ObjectiveTo identify factors predictive of poor prognosis in women with stage III nonserous epithelial ovarian cancer (EOC) who had undergone maximal or optimal primary cytoreductive surgery (CRS) followed by six cycles of intravenous carboplatin/paclitaxel chemotherapy.